Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of remifentanil in mechanically ventilated critically ill patients
ChiCTR2200065542Phase 4Not yet recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil in None, sponsored by Zhongda Hospital, Southeast University. Primary endpoints: Drug concentration–time curve, Area under the concentration–time curve (AUC) and 3 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2200065542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065542.